Exane Derivatives Liva Nova PLC Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Liva Nova PLC stock. As of the latest transaction made, Exane Derivatives holds 47 shares of LIVN stock, worth $2,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 47
-0.0%
Holding current value
$2,197
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LIVN
# of Institutions
261Shares Held
52.9MCall Options Held
316KPut Options Held
127K-
Black Rock Inc. New York, NY6.9MShares$323 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.63MShares$263 Million0.22% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.96MShares$138 Million0.08% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.09MShares$97.8 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$97.5 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.5B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...